Skyhawk strikes a $2.5B collaboration deal with Sanofi


RNA startup Skyhawk Therapeutics has added another big name to its nest of partners: Sanofi ADR.

Previous UMass Memorial's $140M renovation would add 72 beds
Next Insightec wins FDA approval to study novel prostate cancer treatment